News Center

Home page

Peak Report

News reports

We go to the audit

Release time:

2020-07-22

We went to audit

# May 17 -19 . As a member of the supplier audit team, I visited Changzhou Ruiming, Wuxi Yangjian Huaqiang, Suzhou Haishun, Zhejiang Duoling Pharmaceutical Packaging and other companies with my colleagues and conducted a series of audit work.

As one of the key elements of production, the quality and stability of raw materials and auxiliary materials directly determine the stability of the final product quality. In order to ensure the stability of product quality, our manufacturers conduct supplier audits of raw and auxiliary package suppliers every year. This is an on-site audit, including verifying the authenticity of the supplier's qualification documents and inspection reports, whether they have inspection conditions, etc., as well as reviewing its personnel structure, plant facilities and equipment, material management, production process and production management, and quality control laboratory equipment, instruments, document management, etc.

This is my first time to participate in the audit, although I made a corresponding inspection plan for the basic situation of all the suppliers to be inspected before departure. However, once you arrive at the scene, you will still be nervous and do not know where to start. With the warm reception of the representatives of the supply side, our audit work was carried out in an orderly manner.

First of all, we went to the manufacturers of raw materials and chemical raw materials. Before entering the production area, the reception staff of the other party gave us full oral safety education and issued safety helmets, demonstrating the safety awareness that a chemical plant should have. Their production area and office area have obvious regional isolation, effectively avoid cross-contamination. However, some parts of the production site are not doing very well. For example, the unloading position of the raw materials delivered from the warehouse is too random, which is just the place where solar energy is exposed. The label of the raw materials during feeding was removed in advance. In contrast, our factory has done a better job of on-site management. When the raw materials come, there will also be a special unloading position. The labels of the materials will be on the materials until the end of feeding, so as to avoid confusion. We raised these issues with the manufacturer, and the other party accepted them modestly, dealt with them in a timely manner, and said that they would provide rectification reports after all rectifications.

may be an old customer. The manufacturers of composite film (bag) and aluminum foil for drug packaging are a little too casual in reception. We arrived at the factory on the same day but could not find the reception staff. On the spot, there is a sharp contrast between the packaging material manufacturers and our pharmaceutical companies. Although they are also in the D area, their spot is slightly messy and their concept of clearing the spot is somewhat vague. Due to continuous production, the equipment site is easy to leave materials, and the lack of fixed position is slightly messy. They also made rectification immediately after the site was put forward. For our pharmaceutical factory, it is also necessary to change what we have and encourage what we have not.

The third enterprise we went to is a large listed company. Not only can the production and inspection equipment meet the production and inspection requirements, but also the production line is fully automatic production of industry 4.0 , which is fully automated from equipment operation, material and product transportation. In the workshop, the quality of products is also monitored in real time through the central control room, and the positioning of various items is also standardized. The warehouse is a 4 -storey three-dimensional library, which realizes unmanned operation. Their laboratory even has a separate aluminum plastic machine to do challenging experiments, reflecting their pursuit of product quality excellence. All these are worth learning. The wave of industrial automation upgrading is constantly advancing. Although we have not yet entered that stage, we must always maintain our own improvement to meet this wave.

The last company is an enterprise that produces PVC medicinal hard tablets and various composite hard tablets and composite high-barrier packaging materials. Our host is their QC supervisor. To my surprise, their supervisor QC was born in a health school and took part in the inspection work, but he was quite familiar with their process flow and process parameters. This also makes us realize that no matter what position we are in, we should actively learn what we can come into contact with, especially for the process flow and process parameters in production, showing a kind of professionalism for our own industry. During the audit, we found that their workshop also has a special access to visit, each door has access control, for access control is very good. This is where we can learn from. For a workshop, access control is very important, which can effectively avoid problems such as personnel stringing and pollution.

As a production enterprise, our pharmaceutical factory also accepts the audit of our customers every year. Through this rare audit opportunity, I can look at the supplier from the customer's point of view, from which I can objectively see many problems in daily work and production. The first point is that for the reception of customers, special personnel and sufficient relevant information can make customers have a good impression on us; on the production site, various small details determine the quality of the product and whether the production process meets the customer's standards; records and various inspection reports show the true quality of the product. Taking the essence and removing the dross, we will apply the experience gained during this audit to our daily production work, which will certainly give a great impetus to our future work. (Zheng Nan)

More information

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

2020

07-30

Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise

Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has

2020

07-31

Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute

A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody

2020

07-31

The company elects a new board of directors and the board of supervisors to appoint a new management team

On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.

2020

07-31

Peak natural products pollution control results by the industry attention

As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.

2020

07-31

< 1...39 40 41...61 > 跳转到页